The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced a new name for the $100 million, five-year initiative launched in 2020 to increase diversity in clinical trials: The Robert A. Winn Diversity in Clinical Trials Award Program.
Just as reducing your own carbon footprint may not be as easy or straightforward as you would like, building a green portfolio can take time and patience. To get started, here are a few decisions you need to make.
Building on nearly 30 years of history in hunting both new and evolving viruses like HIV and hepatitis, Abbott Virus Hunters sprang into action against COVID-19 knowing that the world needed diagnostic solutions.
2021 was an important year for Vertex and one that positioned the company well for the future as they continued to discover, develop and commercialize transformative medicines for people with serious diseases
ESG data, including the information reported in a CDP response, has become a critical source of decision-useful information for a company’s stakeholders, especially investors.